Currently out of the existing stock ratings of Gavin Scott, 2 are a HOLD (100%).

Gavin Scott

Work Performance Price Targets & Ratings Chart

Analyst Gavin Scott, carries an average stock price target met ratio of 100% that have a potential upside of 85.59% achieved within 50 days. Previously, Gavin Scott worked at JPMORGAN.

Gavin Scott’s has documented 4 price targets and ratings displayed on 1 stocks.

Most recent stock forecast was given on RXRX, Recursion Pharmaceuticals at 13-Nov-2023.

Wall Street Analyst Gavin Scott

Analyst best performing recommendations are on RXRX (RECURSION PHARMACEUTICALS).
The best stock recommendation documented was for RXRX (RECURSION PHARMACEUTICALS) at 11/13/2023. The price target of $10 was fulfilled within 36 days with a profit of $4.17 (71.53%) receiving and performance score of 19.87.

Average potential price target upside

RXRX Recursion Pharmaceuticals

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 16-Mar-2023

$8

$3.97 (98.51%)

$8

13 days ago
(19-Oct-2026)

2/28 (7.14%)

$4.39 (121.61%)

71

Hold Since 18-Aug-2025

$5.5

$1.47 (36.48%)

$5

5 months 18 days ago
(14-May-2026)

1/3 (33.33%)

$2.46 (80.92%)

2

Hold Since 03-Sep-2024

$5.5

$1.98 (56.25%)

$5

5 months 19 days ago
(14-May-2026)

3/6 (50%)

$2.46 (80.92%)

65

Hold Since 26-Feb-2026

$6

$1.97 (48.88%)

$10

8 months 6 days ago
(26-Feb-2026)

2/3 (66.67%)

$2.23 (59.15%)

73

Hold Since 11-May-2021

$10

10 months 16 days ago
(17-Dec-2025)

2/2 (100%)

$4.17 (71.53%)

35

Show more analysts

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?